[HTML][HTML] Acellular Pertussis Vaccine (Infanrix™-DTPa; SB-3) A Review of its Immunogenicity, Protective Efficacy and Tolerability in the Prevention of Bordetella …
SS Patel, AJ Wagstaff - Drugs, 1996 - Springer
Abstract Synopsis SB-3 (Infanrix™-DTPa 1) is one of a new generation of vaccines for
immunisation against pertussis (whooping cough), diphtheria and tetanus. It is a 3 …
immunisation against pertussis (whooping cough), diphtheria and tetanus. It is a 3 …
Design and analysis of three treatment equivalence trials
BL Wiens, B Iglewicz - Controlled clinical trials, 2000 - Elsevier
We consider design and analysis of clinical trials aimed at demonstrating equivalence of
three treatments. We discuss analysis methods that require demonstrating that each pair of …
three treatments. We discuss analysis methods that require demonstrating that each pair of …
[HTML][HTML] Systematic review of immunogenicity and duration of immunity of currently licensed pertussis wP vaccines in children
AM Bagattini, MM Quarti… - Gates Open …, 2022 - gatesopenresearch.org
Background: Currently recommended whole cell pertussis (wP) vaccination schedule for
children includes a 3-dose primary schedule, and at least one booster dose. When …
children includes a 3-dose primary schedule, and at least one booster dose. When …
[PDF][PDF] Comparative study of the reactogenicity of a three-component acellular pertussis vaccine and whole-cell pertussis vaccine administered to healthy Singaporean …
LPC Shek, ESH Khor, GH Tan, KT Low… - … Asian journal of …, 2003 - researchgate.net
The objective of this study was to assess and compare the reactogenicity of GlaxoSmithKline
(GSK) Biologicals' diphtheria-tetanus-tricomponent acellular pertussis vaccine (DTPa) and …
(GSK) Biologicals' diphtheria-tetanus-tricomponent acellular pertussis vaccine (DTPa) and …
Whole‐cell pertussis vaccine in early infancy for the prevention of allergy in children
GP Chacon, J Ramsay… - Cochrane Database …, 2021 - cochranelibrary.com
Background Atopic diseases are the most common chronic conditions of childhood. The
apparent rise in food anaphylaxis in young children over the past three decades is of …
apparent rise in food anaphylaxis in young children over the past three decades is of …
[PDF][PDF] Gates Open Research
AM Bagattini, MM Quarti, MS Martinez-Silveira… - 2022 - researchgate.net
Background: Currently recommended whole cell pertussis (wP) vaccination schedule for
children includes a 3-dose primary schedule, and at least one booster dose. When …
children includes a 3-dose primary schedule, and at least one booster dose. When …
[图书][B] Similarity of three treatment groups
BL Wiens - 1999 - search.proquest.com
Government regulatory agencies require that at least three lots of vaccine be manufactured
to demonstrate that the manufacturing process produces consistent product. Often these lots …
to demonstrate that the manufacturing process produces consistent product. Often these lots …